<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Division of Respiratory Medicine</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D3D3F76B-F553-4E47-8D35-A564C748B364"><gtr:id>D3D3F76B-F553-4E47-8D35-A564C748B364</gtr:id><gtr:firstName>Donna</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/04829FFC-7F01-4150-91BF-69653656B424"><gtr:id>04829FFC-7F01-4150-91BF-69653656B424</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Adcock</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/32D9E0C9-1B3A-4867-9B00-C61C58E93F9D"><gtr:id>32D9E0C9-1B3A-4867-9B00-C61C58E93F9D</gtr:id><gtr:firstName>Derek</gtr:firstName><gtr:surname>Mann</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6017B029-89D1-4AF7-96D8-1EB001171821"><gtr:id>6017B029-89D1-4AF7-96D8-1EB001171821</gtr:id><gtr:firstName>Alan John</gtr:firstName><gtr:surname>Knox</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8C15E1C7-1386-42D8-A8CA-B007569D572D"><gtr:id>8C15E1C7-1386-42D8-A8CA-B007569D572D</gtr:id><gtr:firstName>Howard</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Clark</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1363D81C-25C3-4E07-856F-519FE2F07399"><gtr:id>1363D81C-25C3-4E07-856F-519FE2F07399</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Kirby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B498D825-B151-479C-B97C-AE9177CA3F49"><gtr:id>B498D825-B151-479C-B97C-AE9177CA3F49</gtr:id><gtr:firstName>Ratko</gtr:firstName><gtr:surname>Djukanovic</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A69FFDE3-A452-4F09-A0F3-5CB2DFD5004B"><gtr:id>A69FFDE3-A452-4F09-A0F3-5CB2DFD5004B</gtr:id><gtr:firstName>Fan</gtr:firstName><gtr:surname>Chung</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1205F48B-53ED-48DE-8561-E46FA8C97DDC"><gtr:id>1205F48B-53ED-48DE-8561-E46FA8C97DDC</gtr:id><gtr:firstName>Teresa Dorothy</gtr:firstName><gtr:surname>Tetley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/74444DDA-DAB8-489B-BB05-77633B28142F"><gtr:id>74444DDA-DAB8-489B-BB05-77633B28142F</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Kirkham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D9DFF51-8103-42B7-B910-9735C323F164"><gtr:id>6D9DFF51-8103-42B7-B910-9735C323F164</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F82ECD6A-FF7C-4CA9-B99B-89DD23E48FC7"><gtr:id>F82ECD6A-FF7C-4CA9-B99B-89DD23E48FC7</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Skipp</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B2F4C8D0-A09C-447A-8EBB-D097B2FAA100"><gtr:id>B2F4C8D0-A09C-447A-8EBB-D097B2FAA100</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>O'Connor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CC41D2A8-AB3F-498B-BC55-CE9ED22CF039"><gtr:id>CC41D2A8-AB3F-498B-BC55-CE9ED22CF039</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Brightling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AE6D10A2-CE96-4CD3-9028-D1576E34E910"><gtr:id>AE6D10A2-CE96-4CD3-9028-D1576E34E910</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Fisher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3B4DAFEF-CDF4-498B-B9DC-5914D96301F4"><gtr:id>3B4DAFEF-CDF4-498B-B9DC-5914D96301F4</gtr:id><gtr:firstName>Gisli</gtr:firstName><gtr:surname>Jenkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001367"><gtr:id>C70126BE-599D-467C-BAB6-DEB61FA62C86</gtr:id><gtr:title>The Mechanisms of Inflammation and Immunity in COPD and Their Relationship to Exacerbations and Disease Progression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001367</gtr:grantReference><gtr:abstractText>COPD (which used to be called chronic bronchitis and emphysema) is a common disease which causes considerable difficulty to sufferers. The pharmaceutical industry has been relatively unsuccessful in bringing new treatments to the marketplace for COPD, with many products failing when they are first given to patients because they do not have the effects that were predicted from studies in animals. A way of circumventing this problem is to test new potential medicines in cells and tissues obtained from COPD sufferers and develop laboratory models of COPD using these cells to predict more accurately the approaches that are likely to succeed in patients. Many patients with COPD have progressive changes in their airways and airspaces which are currently unresponsive to any of the current COPD medicines. By understanding how these processes develop, we will identify new pathways that the medicines of tomorrow can target. We will also gain information on molecules that we can measure in patients that will accurately predict whether a patients airways or airspaces are getting destroyed.</gtr:abstractText><gtr:technicalSummary>COPD is characterised by extensive lung remodelling for which there is currently no effective treatment. The co-existence of airways fibrosis and emphysema in COPD points to both pro-fibrotic and tissue destructive mechanisms being operative at the same time, which could be explained by differences in fibroblast function between the airways and parenchyma. The main insults underlying the cycle of tissue damage and frustrated repair that fails to result in restitution of tissue integrity are oxidative stress and infection. We propose that the effect of these is channelled through the epithelium to the underlying mesenchymal cells, resulting in tissue fibrosis in the airways and alveolar destruction. 
 In a step change for translational research and drug development, this workpackage brings together leading academic respiratory research groups and pharmaceutical companies to address the widely perceived key unmet needs in COPD: 1) understanding the mechanisms of injury and repair, 2) validated human lung tissue models for the ex vivo study of COPD pathogenesis, 3) pre-clinical proof of efficacy of drugs in development and 4) biomarkers which assist drug development.
 Our hypothesis is that lung epithelial damage, caused by a combination of exogenous and endogenous radical oxygen species and virus infections, drives remodelling in COPD, with varying degrees of fibrosis and destruction in the airway and parenchymal compartments depending on the relative involvement of TGF? and metalloproteases. We will apply our validated lung ex vivo models using samples from deeply characterised COPD patients and controls, enabling integration of clinical and experimental data that should help focus drug development to appropriate COPD phenotypes. We will use bronchial and alveolar epithelial cultures alone or co-cultures with fibroblasts or smooth muscle cells, progressing to whole tissue explant (biopsy, wedge resection, dissected small airways); applying disease-relevant stimuli, including oxidants and viruses, we will study disease mechanisms, looking for differences between the airways and lung parenchyma. We will extend our pilot observations of carbonyl-modified proteins which act as auto-antigens and induce auto-antibodies in correlation with COPD severity and study their destructive role. Progressing from simple, single cell type (high-throughput) models to complex tissue explants, we will provide proof of efficacy for an array of tool compounds from pharma. The focused and well integrated approach that we are applying should deliver within 2-3 years a step change in the understanding of remodelling mechanisms in COPD and an advance in drug development through provision of proof of concept for novel drugs.</gtr:technicalSummary><gtr:fund><gtr:end>2013-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1095618</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Mayfest University of Nottingham</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8B51A950-0C2B-407F-A444-BFAA10221A36</gtr:id><gtr:impact>Open day where research presented</gtr:impact><gtr:outcomeId>56cc42a9e57a88.79516739</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FAA7887D-FF99-4D35-8ADC-7AB49143B71E</gtr:id><gtr:title>The ERS Research Agency: the beginning.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28edbd0fb059c16eb29430a4537a3516"><gtr:id>28edbd0fb059c16eb29430a4537a3516</gtr:id><gtr:otherNames>Soriano JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58c5665de8ce25.87825266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14164178-7ECC-417A-848A-CF00206AACEC</gtr:id><gtr:title>Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma Studies.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1cd5df99f555bb626ceaff6e2d91341"><gtr:id>c1cd5df99f555bb626ceaff6e2d91341</gtr:id><gtr:otherNames>Loza MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>58c5665e1c6d31.67172400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA490303-80A2-4F0B-A4FD-74D0B76AA666</gtr:id><gtr:title>Exosomes and Exosomal miRNA in Respiratory Diseases.</gtr:title><gtr:parentPublicationTitle>Mediators of inflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/959b58e56e2d7ad127e88825b8e8faf8"><gtr:id>959b58e56e2d7ad127e88825b8e8faf8</gtr:id><gtr:otherNames>Alipoor SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-9351</gtr:issn><gtr:outcomeId>58c56658dc6114.43818816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E6B7DA-5A57-4DF3-95F3-696D95042F35</gtr:id><gtr:title>Common features of tuberculosis and sarcoidosis.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c5665b5cf5f2.55865458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D00F6987-00B4-4455-B8C5-8A8FE3C3143A</gtr:id><gtr:title>Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1cd5df99f555bb626ceaff6e2d91341"><gtr:id>c1cd5df99f555bb626ceaff6e2d91341</gtr:id><gtr:otherNames>Loza MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>58c5665ae03966.61730769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F67E18-E01B-456E-B835-D1320525C6D5</gtr:id><gtr:title>The &amp;quot;Iron&amp;quot;-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1b35d2011063a4a4f63717e5825aef5"><gtr:id>f1b35d2011063a4a4f63717e5825aef5</gtr:id><gtr:otherNames>Cloonan SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5a353a9b97ec02.72753559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F031579D-53AE-4EA8-93A0-0F3005019A8F</gtr:id><gtr:title>The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Gu&amp;eacute;rin by RNA sequencing.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c5665bb54373.42065311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1B1C634-4B99-4A85-8068-8B9C0CA3F090</gtr:id><gtr:title>Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f956cfe83a8086d1cef5118e1d4411e"><gtr:id>8f956cfe83a8086d1cef5118e1d4411e</gtr:id><gtr:otherNames>Athari SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>58c5665c586d35.63850910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28538E66-03C4-49E6-AE6F-28D271D54E76</gtr:id><gtr:title>ERS Lung Science Conference 2016 report.</gtr:title><gtr:parentPublicationTitle>European respiratory review : an official journal of the European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a0f1395bd6abe1bf3d3ab9085491f24"><gtr:id>1a0f1395bd6abe1bf3d3ab9085491f24</gtr:id><gtr:otherNames>De Meulder B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-9180</gtr:issn><gtr:outcomeId>58c5665d58c076.15711098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3D0F980-5E62-4933-9F02-E64C0B410D10</gtr:id><gtr:title>Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.</gtr:title><gtr:parentPublicationTitle>The journal of nutrition, health &amp; aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f59e58738a90493179d2cbcfa849c8f"><gtr:id>0f59e58738a90493179d2cbcfa849c8f</gtr:id><gtr:otherNames>Bousquet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1279-7707</gtr:issn><gtr:outcomeId>58c5665a735720.18151070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9479D93-351F-41DA-967B-2C23C33C1F6B</gtr:id><gtr:title>Cancers Related to Immunodeficiencies: Update and Perspectives.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>58c566584a3004.08426364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA01FC03-C15E-4F27-9384-0C91239896F0</gtr:id><gtr:title>In vitro effects of water-pipe smoke condensate on the endocytic activity of Type II alveolar epithelial cells (A549) with bacillus Calmette-Gu&amp;eacute;rin.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee684f9047e0bd9660d2d01912b5dee3"><gtr:id>ee684f9047e0bd9660d2d01912b5dee3</gtr:id><gtr:otherNames>Adcock IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c5665bdf6368.19283874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A75591-4951-44EF-92EB-6FEFC5637AA6</gtr:id><gtr:title>A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da05254e5a9b584a40987be27d45d755"><gtr:id>da05254e5a9b584a40987be27d45d755</gtr:id><gtr:otherNames>Kuo CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58c56659809326.61097650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3856ABB-2819-491B-B33D-00EA8B09C3D2</gtr:id><gtr:title>COPD immunopathology.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/775a81de45418583b5b95a6c9400a92e"><gtr:id>775a81de45418583b5b95a6c9400a92e</gtr:id><gtr:otherNames>Caramori G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn><gtr:outcomeId>58c56658ad1756.99195941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F574FEE-C696-4C11-A53A-E1A04A4A9808</gtr:id><gtr:title>Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1231a4bb8f20a4969d2b20cf5608cd75"><gtr:id>1231a4bb8f20a4969d2b20cf5608cd75</gtr:id><gtr:otherNames>Langley GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>58c56659a95223.90201773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>190964E8-8520-4ADB-9F53-CAEDF4ECAFE8</gtr:id><gtr:title>Investigation of urine lipoarabinomannan in human immunodeficiency virus patients with or without coinfection with Tuberculosis in Iran.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf10dd3fa1c9dc0d9eb94845f89b1cf8"><gtr:id>bf10dd3fa1c9dc0d9eb94845f89b1cf8</gtr:id><gtr:otherNames>Tabarsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c5665b8c5b04.78914868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AEF6364-84C6-437E-99D6-E013F09D3C0F</gtr:id><gtr:title>The role of pattern recognition receptors in lung sarcoidosis.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>58c5665a169660.40338037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C62604D-C6DB-40E6-9102-5A524DFF1623</gtr:id><gtr:title>U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dbffdc92ee9f2a9ddfd6cabde8263b0"><gtr:id>6dbffdc92ee9f2a9ddfd6cabde8263b0</gtr:id><gtr:otherNames>Lefaudeux D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58c5665cba7527.81293183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E86F093F-D173-403E-92AE-DEF39A127C0C</gtr:id><gtr:title>Hypoxia-Inducible Factor-1a Regulates CD55 in Airway Epithelium.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37010874d06b58976753f72fa953ddfb"><gtr:id>37010874d06b58976753f72fa953ddfb</gtr:id><gtr:otherNames>Pandya PH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>58bd984b45ad61.70152181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0980E44-5863-4C93-8479-72AD9A0F3771</gtr:id><gtr:title>Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/225aa78682bfd708baa17a03ae70a4d9"><gtr:id>225aa78682bfd708baa17a03ae70a4d9</gtr:id><gtr:otherNames>Wilson SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58c5665c8ce681.02378421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8535F80-7C9D-43A7-8858-78FF00C92B9C</gtr:id><gtr:title>A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfc1acf3b0c9a6db0e0c8296a38017ca"><gtr:id>dfc1acf3b0c9a6db0e0c8296a38017ca</gtr:id><gtr:otherNames>Bigler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58c5665b2d9e30.78507946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>510D88EA-2BB7-4C2F-9B07-9FED1C4F8E8A</gtr:id><gtr:title>Mechanical Strain Causes Adaptive Change in Bronchial Fibroblasts Enhancing Profibrotic and Inflammatory Responses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df6218fdbbdd96ccbd9e67e22d1b5ae3"><gtr:id>df6218fdbbdd96ccbd9e67e22d1b5ae3</gtr:id><gtr:otherNames>Manuyakorn W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58bd97a12eb486.76354434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46F039FA-8555-4419-9DC7-4C5490CDA780</gtr:id><gtr:title>The roles of miRNAs as potential biomarkers in lung diseases.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/959b58e56e2d7ad127e88825b8e8faf8"><gtr:id>959b58e56e2d7ad127e88825b8e8faf8</gtr:id><gtr:otherNames>Alipoor SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>58c5665c154c23.61093305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9080E63A-541A-4C54-BABC-0B882519B1CB</gtr:id><gtr:title>Animal models of COPD: What do they tell us?</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a692102c18c95a1f2217f9c024bb0c"><gtr:id>02a692102c18c95a1f2217f9c024bb0c</gtr:id><gtr:otherNames>Jones B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>58c5665aa9e5c1.54973002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22690DD1-E047-47DC-8CA7-BEC780B6E725</gtr:id><gtr:title>Pattern recognitions receptors in immunodeficiency disorders.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>58c5665a41b0e5.94312706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF39FC40-2BAD-4EC3-B84D-3BB0378D1E9E</gtr:id><gtr:title>Role of Innate Lymphoid Cells in Lung Disease.</gtr:title><gtr:parentPublicationTitle>Iranian journal of allergy, asthma, and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6979fd0cf76562bc32806454919de938"><gtr:id>6979fd0cf76562bc32806454919de938</gtr:id><gtr:otherNames>Marashian SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1735-1502</gtr:issn><gtr:outcomeId>58c569103ea2e7.00169666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FD2E065-C8C4-4D92-A566-6DE1B33AA4EE</gtr:id><gtr:title>Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5db30e5397983d6b4ef21cca64df00ab"><gtr:id>5db30e5397983d6b4ef21cca64df00ab</gtr:id><gtr:otherNames>Austin PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58c5665944e4d2.27291932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC62782-3F66-4CAD-9041-0C73B133E59F</gtr:id><gtr:title>Reduced Phagocytic Capacity of Blood Monocyte/Macrophages in Tuberculosis Patients Is Further Reduced by Smoking.</gtr:title><gtr:parentPublicationTitle>Iranian journal of allergy, asthma, and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8671ddb81402c583113e12c70cbea71a"><gtr:id>8671ddb81402c583113e12c70cbea71a</gtr:id><gtr:otherNames>Aryanpur M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1735-1502</gtr:issn><gtr:outcomeId>58c5665d81aad5.64579998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34D7CBE1-1E02-4413-BEB3-E2F88B490386</gtr:id><gtr:title>Adapting the Electrospinning Process to Provide Three Unique Environments for a Tri-layered In Vitro Model of the Airway Wall.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/870415883264623c842b69456be48d87"><gtr:id>870415883264623c842b69456be48d87</gtr:id><gtr:otherNames>Bridge JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>56e004190ce729.68672313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE99FD52-A6DB-49AB-99AF-768B457C5551</gtr:id><gtr:title>Susceptibility to influenza virus infection of bronchial biopsies in asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe060351eab4aa62e09bd1d48919986"><gtr:id>4fe060351eab4aa62e09bd1d48919986</gtr:id><gtr:otherNames>Nicholas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58c566591b6eb9.07784801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1D4CFAC-4CB6-4EE2-9E0B-25882CB868B7</gtr:id><gtr:title>The Roles of T Helper 1, T Helper 17 and Regulatory T Cells in the Pathogenesis of Sarcoidosis.</gtr:title><gtr:parentPublicationTitle>Iranian journal of allergy, asthma, and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac1f9b446f397a91008a066abe4dbb8"><gtr:id>cac1f9b446f397a91008a066abe4dbb8</gtr:id><gtr:otherNames>Mortaz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1735-1502</gtr:issn><gtr:outcomeId>58c5665d2decf8.52414863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4732B035-6D31-4C84-86CE-BABAC9029F85</gtr:id><gtr:title>AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f59e58738a90493179d2cbcfa849c8f"><gtr:id>0f59e58738a90493179d2cbcfa849c8f</gtr:id><gtr:otherNames>Bousquet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58c5665daca100.48526013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3CDA21B-8C0B-4398-A70F-AEB110225A97</gtr:id><gtr:title>MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94bb5284b4bffb3b00cac63de09f6493"><gtr:id>94bb5284b4bffb3b00cac63de09f6493</gtr:id><gtr:otherNames>Kim RY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58c56659d7efc9.70138923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7739FDAF-1255-4395-B428-924EFBF87C45</gtr:id><gtr:title>Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eb715eb6ff8dfb5b177c34b6e5e4371"><gtr:id>5eb715eb6ff8dfb5b177c34b6e5e4371</gtr:id><gtr:otherNames>Wiegman CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56e0041a2fe560.85887955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B90D8D06-D1C9-432A-8854-69880C9AEE85</gtr:id><gtr:title>Epigenome-modifying tools in asthma.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06c003303a545211acbfed45e8dc9e6d"><gtr:id>06c003303a545211acbfed45e8dc9e6d</gtr:id><gtr:otherNames>Brook PO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>5a324db8a45f95.96631109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA0525D3-9669-45F6-979F-1FAEF7EFDBBB</gtr:id><gtr:title>Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study.</gtr:title><gtr:parentPublicationTitle>Journal of inflammation (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a53648392cd7f16024120e680a4a6d"><gtr:id>b9a53648392cd7f16024120e680a4a6d</gtr:id><gtr:otherNames>Poletti D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1476-9255</gtr:issn><gtr:outcomeId>58c566587d2f98.30628388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80FD8893-780E-492C-B68E-D24825D2B7B0</gtr:id><gtr:title>IL-1a mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit.</gtr:title><gtr:parentPublicationTitle>Tissue barriers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5397a69022a7a6256a8e3599e475afa"><gtr:id>c5397a69022a7a6256a8e3599e475afa</gtr:id><gtr:otherNames>Hill AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-8362</gtr:issn><gtr:outcomeId>58bd97a0f1ad71.24028780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A6A717-050B-4ABF-80BD-28A678EED78E</gtr:id><gtr:title>Investigating NF-?B signaling in lung fibroblasts in 2D and 3D culture systems.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24f2e8d574d925871066e5b5855dea20"><gtr:id>24f2e8d574d925871066e5b5855dea20</gtr:id><gtr:otherNames>Htwe SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>56e0029babad31.23063643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22DFF562-18C1-45D8-B29B-02771C926D1C</gtr:id><gtr:title>An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebc55452bb6af180154f4bb7236b32dd"><gtr:id>ebc55452bb6af180154f4bb7236b32dd</gtr:id><gtr:otherNames>Ravanetti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>58c5665ceed151.72788954</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001367</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>